Tower Research Capital LLC (Trc) Precigen, Inc. Transaction History

Tower Research Capital LLC (Trc)

$3.68 Billion
Q3 2024

A detailed history of Tower Research Capital LLC (Trc) transactions in Precigen, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 9,111 shares of PGEN stock, worth $6,833. This represents 0.0% of its overall portfolio holdings.

Number of Shares

9,111

Previous 21,416 57.46%

Holding current value

$6,833

Previous $33,000 75.76%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$0.91 - $1.88 $11,197 - $23,133	-12,305 Reduced 57.46%	9,111 $8,000
Q2 2024 Aug 13, 2024	BUY	$1.27 - $1.75 $25,718 - $35,439	20,251 Added 1738.28%	21,416 $33,000
Q1 2024 May 15, 2024	SELL	$1.21 - $1.75 $8,214 - $11,880	-6,789 Reduced 85.35%	1,165 $1,000
Q4 2023 Feb 13, 2024	BUY	$0.89 - $1.41 $2,078 - $3,292	2,335 Added 41.56%	7,954 $10,000
Q3 2023 Nov 14, 2023	SELL	$1.08 - $1.85 $4,444 - $7,612	-4,115 Reduced 42.27%	5,619 $7,000
Q2 2023 Aug 14, 2023	SELL	$0.96 - $1.4 $26,441 - $38,560	-27,543 Reduced 73.89%	9,734 $11,000
Q1 2023 May 09, 2023	SELL	$0.88 - $2.19 $3,839 - $9,554	-4,363 Reduced 10.48%	37,277 $40,000
Q4 2022 Feb 10, 2023	BUY	$1.27 - $2.26 $18,478 - $32,883	14,550 Added 53.71%	41,640 $63,000
Q3 2022 Nov 10, 2022	BUY	$1.41 - $2.79 $1,779 - $3,520	1,262 Added 4.89%	27,090 $57,000
Q2 2022 Aug 15, 2022	SELL	$1.15 - $2.53 $400 - $880	-348 Reduced 1.33%	25,828 $35,000
Q1 2022 May 12, 2022	BUY	$1.91 - $3.98 $21,642 - $45,097	11,331 Added 76.33%	26,176 $55,000
Q4 2021 Feb 14, 2022	SELL	$3.53 - $5.5 $21,921 - $34,155	-6,210 Reduced 29.49%	14,845 $55,000
Q3 2021 Nov 15, 2021	BUY	$4.99 - $6.55 $63,263 - $83,040	12,678 Added 151.34%	21,055 $105,000
Q2 2021 Aug 16, 2021	SELL	$6.24 - $8.22 $3,544 - $4,668	-568 Reduced 6.35%	8,377 $54,000
Q1 2021 May 17, 2021	BUY	$6.74 - $10.95 $41,565 - $67,528	6,167 Added 221.99%	8,945 $62,000
Q4 2020 Feb 16, 2021	SELL	$3.75 - $10.56 $63,450 - $178,675	-16,920 Reduced 85.9%	2,778 $28,000
Q3 2020 Nov 16, 2020	BUY	$3.5 - $6.2 $21,245 - $37,634	6,070 Added 44.54%	19,698 $69,000
Q2 2020 Aug 13, 2020	BUY	$2.16 - $5.46 $29,436 - $74,408	13,628 New	13,628 $68,000

Others Institutions Holding PGEN

# of Institutions

143

Shares Held

159M

Call Options Held

232K

Put Options Held

69K

View Full List

About PRECIGEN, INC.

Ticker PGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 208,150,000
Market Cap $156M
Description
Precigen, Inc. discovers and develops the next generation of gene and cellular therapies in the United States. It also provides disease-modifying therapeutics; genetically engineered swine for regenerative medicine applications; and reproductive and embryo transfer technologies. In addition, the company offers UltraVector platform that incorpora...

More about PGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Account

Tower Research Capital LLC (Trc) Precigen, Inc. Transaction History